A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
Public ClinicalTrials.gov record NCT06088199. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-center, Open-label, Single-arm Study to Assess the Safety of Apremilast (AMG 407) in Pediatric Participants From 6 Through 17 Years of Age With Mild to Moderate Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this post-marketing study is to assess the safety and tolerability of apremilast in pediatric participants (ages 6 through 17 years) with mild to moderate plaque psoriasis.
Study identification
- NCT ID
- NCT06088199
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 24, 2023 (Actual)
- Primary completion
- Aug 12, 2026 (Actual)
- Completion
- Aug 12, 2026 (Actual)
- Last update posted
- Aug 28, 2026
2023 – 2026
United States locations
- U.S. sites
- 30
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| Affiliated Dermatology | Scottsdale | Arizona | 85255 | — |
| Clear Dermatology | Scottsdale | Arizona | 85255 | — |
| Johnson Dermatology Clinic | Fort Smith | Arkansas | 72916 | — |
| Avance Clinical Trials | Laguna Niguel | California | 92677 | — |
| University of California Irvine | Orange | California | 92868 | — |
| MedDerm Associates | San Diego | California | 92103 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| California Dermatology Institute | Thousand Oaks | California | 91320 | — |
| Pediatric Skin Research LLC | Coral Gables | Florida | 33146 | — |
| Ciocca Dermatology | Miami | Florida | 33173 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| Endeavor Health Clinical Trials Center | Skokie | Illinois | 60077 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| Southern Indiana Clinical Trials | New Albany | Indiana | 47150 | — |
| Great Lakes Research Group Inc- Sheffield | Bay City | Michigan | 48706 | — |
| Henry Ford Medical Center - New Center One | Detroit | Michigan | 48202 | — |
| Dermatology and Skin Cancer Center of Lees Summit | Lee's Summit | Missouri | 64064 | — |
| Boeson Research | Missoula | Montana | 59804 | — |
| Empire Dermatology | East Syracuse | New York | 13057 | — |
| State University of New York, Downstate Medical Center | Manhasset | New York | 11030 | — |
| OptiSkin Medical | New York | New York | 10029 | — |
| Hightower Clinical LLC | Oklahoma City | Oklahoma | 73120 | — |
| Dermatology Research Center of Oklahoma, PLLC | Tulsa | Oklahoma | 74132 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Studies in Dermatology LLC | Cypress | Texas | 77429 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
| Stride Clinical Research LLC | Sugar Land | Texas | 77479 | — |
| Frontier Derm Partners | Mill Creek | Washington | 98012 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06088199, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06088199 live on ClinicalTrials.gov.